Medical and economic burden of influenza in the elderly population in central and eastern European countries

Human Vaccines and Immunotherapeutics

Volumn 10, Issue 2, 2014, Pages 428-440

  Kovács, Gábor ^a   Kaló, Zoltán ^b   Jahnz Rozyk, Karina ^c   Kyncl, Jan ^d   Csohan, Agnes ^e   Pistol, Adriana ^f   Leleka, Mariya ^g   Kipshakbaev, Rafail ^h   Durand, Laure ^h   Macabeo, Bérengère ^a  

^a Syreon Research Institute   (Hungary)

^b MILITARY INSTITUTE OF MEDICINE   (Poland)

^c NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

^d NATIONAL CENTER FOR EPIDEMIOLOGY   (Hungary)

^e NATIONAL INSTITUTE OF PUBLIC HEALTH   (Romania)

^f I HORBACHEVSKY TERNOPIL NATIONAL MEDICAL UNIVERSITY   (Ukraine)

^g ISPOR Chapter Kazakhstan   (Kazakhstan)

^h SANOFI PASTEUR   (France)

Author keywords

Cost of illness; Elderly; Health care system; Influenza; Public health; Vaccination

Indexed keywords

AGING; ARTICLE; CASE MANAGEMENT; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; CZECH REPUBLIC; DISEASE SURVEILLANCE; EUROPE; EVIDENCE BASED PRACTICE; GERIATRICS; HEALTH CARE COST; HEALTH CARE POLICY; HOSPITALIZATION; HUMAN; HUNGARY; INCIDENCE; INFLUENZA; KAZAKHSTAN; POLAND; POPULATION SIZE; PREVALENCE; PUBLIC HEALTH; ROMANIA; STANDARDIZATION; UKRAINE; AGED; ECONOMICS; EPIDEMIOLOGY; INFLUENZA, HUMAN; MALE; UTILIZATION; VACCINATION; VERY ELDERLY;

INFLUENZA VACCINE;

AGED; AGED, 80 AND OVER; EUROPE; HEALTH CARE COSTS; HUMANS; INCIDENCE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; PREVALENCE; VACCINATION;

EID: 84896958145     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.26886     Document Type: Article

References (43)

1. World Health Organization. Influenza. Fact Sheets. 2003. Available from: http://www.who.int/ mediacentre/factsheets/2003/fs211/en/.
2. Rothberg MB, Haessler SD, Brown RB. Complications of viral influenza. Am J Med 2008; 121:258-64; PMID:18374680; http://dx.doi. org/10.1016/j.amjmed.2007. 10.040 (Pubitemid 351417852)
3. World Health Organization. Comparing deaths from pandemic and seasonal influenza. Global Alert and Response. 2009. Available from: http://www.who. int/csr/disease/swinef lu/notes/briefing20091222/ en/.
4. Thompson WW, Comanor L, Shay DK. Epidemiology of seasonal influenza: use of surveillance data and statistical models to estimate the burden of disease. J Infect Dis 2006; 194(Suppl 2):S82-91; PMID:17163394; http://dx.doi.org/10.1086/ 507558 (Pubitemid 44630951)
5. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289:179-86; PMID:12517228; http://dx.doi.org/10.1001/ jama.289.2.179 (Pubitemid 36068705)
6. Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, Bridges CB. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 2007; 25:5086-96; PMID:17544181; http://dx.doi. org/10.1016/j.vaccine.2007.03.046 (Pubitemid 46879994)
7. Hannoun C, Megas F, Piercy J. Immunogenicity and protective efficacy of influenza vaccination. Virus Res 2004; 103:133-8; PMID:15163501; http:// dx.doi.org/10.1016/j.virusres.2004.02.025 (Pubitemid 38649072)
8. Webster RG. Immunity to influenza in the elderly. Vaccine 2000; 18:1686-9; PMID:10689149; http:// dx.doi.org/10.1016/S0264-410X(99)00507-1 (Pubitemid 30109529)
9. Lugnér AK, van Boven M, de Vries R, Postma MJ, Wallinga J. Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis. BMJ 2012; 345:e4445; PMID:22791791; http://dx.doi.org/10.1136/bmj. e4445
10. Gasparini R, Amicizia D, Lai PL, Panatto D. Clinical and socioeconomic impact of seasonal and pandemic influenza in adults and the elderly. Hum Vaccin Immunother 2012; 8:21-8; PMID:22252007; http:// dx.doi.org/10.4161/hv.8.1.17622
11. Brydak L, Roiz J, Faivre P, Reygrobellet C. Implementing an influenza vaccination programme for adults aged ≥65 years in Poland: a cost-effectiveness analysis. Clin Drug Investig 2012; 32:73-85; PMID:22201294; http://dx.doi. org/10.2165/11594030-000000000-00000
12. Jahnz-Rózyk K. [Health economic impact of viral respiratory infections and pneumonia diseases on the elderly population in Poland]. Pol Merkuriusz Lek 2010; 29:37-40
13. Lanzieri G. The greying of the baby boomers, a century-long view of ageing in European populations. Statistics in Focus 2011; 23. Available from: http:// epp.eurostat.ec.europa.eu/cache/ITYOFFPUB/ KS-SF-11-023/EN/KS-SF-11-023- EN.PDF
14. Mereckiene J, Cotter S, Weber JT, Nicoll A, Lévy-Bruhl D, Ferro A, Tridente G, Zanoni G, Berra P, Salmaso S, et al.; VENICE Gatekeepers Group. Low coverage of seasonal influenza vaccination in the elderly in many European countries. Euro Surveill 2008; 13:19001; PMID:18926107
15. Rechel B, Doyle Y, Grundy E, McKee M. How can health systems respond to population ageing? World Health Organization 2009 and World Health Organization, on behalf of the European Observatory on Health Systems and Policies; 2009. Available from: http://www.euro.who.int/data/assets/pdf file/0004/64966/E92560. pdf
16. World Health Organization. Influenza vaccines: WHO position paper. Wkly Epidemiol Rec 2005; 33:279-87
17. Blank P, Schwenkglenks M, Szucs TD. The impact of European vaccination policies on seasonal influenza vaccination coverage rates in the elderly. Hum Vaccin Immunother 2012; 8:328-35; PMID:22327498; http://dx.doi.org/10.4161/hv. 18629
18. World Health Organization-Europe. WHO/ Europe recommendations on influenza vaccination during the 2011-2012 winter season. 2011. Available from: http://www.euro. who.int /data /assets /pdff ile /0008/152297/ EURO20112012-flu-vacc-recV2.pdf
19. Centers for Disease Control and Prevention (CDC). Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 2011; 60:1128-32; PMID:21866086
20. The Council of the European Union. Council recommendation of 22 December 2009 on seasonal influenza vaccination (2009/1019/EU). Official Journal of the European Union. 2009. Available from: http:// eur-lex.europa.eu/LexUriServ/ LexUriServ.do?uri=O J:L:2009:348:0071:0072:EN:PDF
21. Vaccines against influenza WHO position paper -November 2012. Wkly Epidemiol Rec 2012; 87:461-76; PMID:23210147
22. Jansen AG, Sanders EA, Nichol KL, van Loon AM, Hoes AW, Hak E. Decline in influenza-associated mortality among Dutch elderly following the introduction of a nationwide vaccination program. Vaccine 2008; 26:5567-74; PMID:18722492; http:// dx.doi.org/10.1016/j.vaccine.2008.08.003
23. Boyle JR, Sparks RS, Keijzers GB, Crilly JL, Lind JF, Ryan LM. Prediction and surveillance of influenza epidemics. Med J Aust 2011; 194:S28-33; PMID:21401485
24. EuroFlu. The influenza season has begun in the WHO European Region EuroFlu Electronic Bulletin. 2012. Available from: http://www.euroflu.org/cgif iles/bulletinv2.cgi?display=1&code=467&bulle tin=467
25. EuroFlu. Low and decreasing influenza activity in most countries of the WHO European Region. EuroFlu Electronic Bulletin. 2012. Available from: https://www.isirv.org/cgi-files/bulletinv2.cgi?displ ay=1&code= 442&bulletin=442
26. O'Flanagan DC, Cotter S, Mereckiene J. Vaccine European New Integrated Collaboration Effort (VENICE). Pandemic A(H1N1)2009 influenza vaccination survey, influenza season 2009/2010. VENICE. 2011. Available from: http://venice. cineca.org/FinalReportVENICEPandemic Influenza2009.pdf
27. European Centre for Disease Prevention and Control. Influenza vaccines from a public health perspective: Where are we today? Stockholm, 2012. Available from: http://www.ecdc.europa.eu/en/aboutus/ organisation/director%20speeches/ ecdc-director-seasonal-influenza-ivw-2012oct10.pdf
28. Scuffham PA, West PA. Economic evaluation of strategies for the control and management of influenza in Europe. Vaccine 2002; 20:2562-78; PMID:12057614; http://dx.doi.org/10.1016/ S0264-410X(02)00154-8 (Pubitemid 34615597)
29. World Health Organization. Clinical management of influenza and other acute respiratory illness in resource-limited settings: learning from the influenza pandemic (H1N1) 2009. Meeting Report. Geneva, 2010. Available from: http:// w w w.wh o . i nt / i n f l u e n z a / p a t i e n t c a r e / clinical/858-WHOGIPReportA4WEBFA.pdf
30. Cernescu C, Ruta S-M. Distinctive features in the evolution of 2009 influenza pandemic in East European countries. Proc Rom Acad, Series B 2010; 2:99-106
31. Ercole A, Taylor BL, Rhodes A, Menon DK. Modelling the impact of an influenza A/H1N1 pandemic on critical care demand from early pathogenicity data: the case for sentinel reporting. Anaesthesia 2009; 64:937-41; PMID:19645759; http://dx.doi. org/10.1111/j.1365-2044.2009.06070.x
32. van Noort SP, Muehlen M, Rebelo de Andrade H, Koppeschaar C, Lima Lourenço JM, Gomes MG. Gripenet: an internet-based system to monitor influenza-like illness uniformly across Europe. Euro Surveill 2007; 12:E5-6; PMID:17991409
33. Friesema IH, Koppeschaar CE, Donker GA, Dijkstra F, van Noort SP, Smallenburg R, van der Hoek W, van der Sande MA. Internet-based monitoring of influenza-like illness in the general population: experience of five influenza seasons in The Netherlands. Vaccine 2009; 27:6353-7; PMID:19840672; http:// dx.doi.org/10.1016/j.vaccine.2009.05.042
34. Tilston NL, Eames KT, Paolotti D, Ealden T, Edmunds WJ. Internet-based surveillance of Influenza-like-illness in the UK during the 2009 H1N1 influenza pandemic. BMC Public Health 2010; 10:650; PMID:20979640; http://dx.doi. org/10.1186/1471-2458-10-650
35. Marquet RL, Bartelds AI, van Noort SP, Koppeschaar CE, Paget J, Schellevis FG, van der Zee J. Internetbased monitoring of influenza-like illness (ILI) in the general population of the Netherlands during the 2003-2004 influenza season. BMC Public Health 2006; 6:242; PMID:17018161; http://dx.doi. org/10.1186/1471-2458-6-242
36. U.S. Department of Labor. Bureau of Labor Statistics. Illness-related work absences during flu season. Issues in Labor Statistics. 2010. Available from: http:// www.bls.gov/opub/ils/pdf/opbils83.pdf
37. Shellenback K. Child care & parent productivity: making the business case. Linking economic development and child care research project. Ithaca (NY): Cornell University, Cornell Cooperative extension department of city and regional planning. 2004. Available from: http://annazavaritt.blog.ilsole24ore. com/files/making-the-business-case-2.pdf
38. Jefferson T. Influenza vaccination: policy versus evidence. BMJ 2006; 333:912-5; PMID:17068038; http://dx.doi.org/10.1136/bmj.38995.531701.80 (Pubitemid 44683514)
39. Jefferson T, Di Pietrantonj C, Al-Ansary LA, Ferroni E, Thorning S, Thomas RE. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 2010; CD004876; PMID:20166072
40. Kissling E, Valenciano M, Falcao J, Larrauri A, Widgren K, Pitigoi D, Oroszi B, Nunes B, Savulescu C, Mazick A, et al. "I-MOVE" towards monitoring seasonal and pandemic influenza vaccine effectiveness: lessons learnt from a pilot multi-centric casecontrol study in Europe, 2008-9. Euro Surveill 2009; 14:19388; PMID:19941774
41. Gasparini R, Amicizia D, Lai PL, Rossi S, Panatto D. Effectiveness of adjuvanted seasonal influenza vaccines (Inflexal V ® and Fluad ® ) in preventing hospitalization for influenza and pneumonia in the elderly: a matched case-control study. Hum Vaccin Immunother 2013; 9:144-52; PMID:23143775; http://dx.doi.org/10.4161/hv.22231
42. Thompson M. Updated Adjusted Estimates of 2012-13 Seasonal Influenza Vaccine Effectiveness in the United States. 2013 National adult immunization summit. Atlanta, Georgia, 2013.
43. Puig-Barberà J, Díez-Domingo J, Arnedo-Pena A, Ruiz-García M, Pérez-Vilar S, Micó-Esparza JL, Belenguer-Varea A, Carratalá-Munuera C, Gil-Guillén V, Schwarz-Chavarri H. Effectiveness of the 2010-2011 seasonal influenza vaccine in preventing confirmed influenza hospitalizations in adults: a case-case comparison, case-control study. Vaccine 2012; 30:5714-20; PMID:22819720; http://dx.doi. org/10.1016/j.vaccine.2012.07.006